Cite

HARVARD Citation

    Wu, L. et al. (2018). Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma. Oncoimmunology. p. . [Online]. 
  
Back to record